Table 3.
HR | 95% CI | p value | |
---|---|---|---|
Number of transplantations | |||
1 | Ref | ||
2 | 1.5 | 1.1–2.0 | 0.003 |
≥3 | 3.3 | 1.7–6.1 | <0.001 |
| |||
Recipient age (years) | |||
<50 | Ref | ||
50–59 | 1.2 | 0.9–1.6 | 0.1 |
60–69 | 1.9 | 1.4–2.5 | <0.001 |
≥70 | 2.9 | 1.8–4.8 | <0.001 |
| |||
Time on dialysis (years) | |||
<1 | Ref | ||
1-2 | 1.2 | 0.9–1.5 | 0.2 |
2–4 | 1.4 | 1.1–1.8 | 0.003 |
>4 | 1.7 | 1.3–2.2 | <0.001 |
| |||
Charlson–Deyo index∗ | |||
2 (kidney disease only) | Ref | ||
3 (≤1 mild comorbidity) | 1.2 | 0.9–1.6 | 0.1 |
4 (≥2 mild or 1 moderate comorbidity) | 1.8 | 1.4–2.4 | <0.001 |
≥5 (multiple comorbidities) | 2.3 | 1.7–3.0 | <0.001 |
| |||
Smoking | 1.3 | 1.1–1.5 | 0.01 |
| |||
Comorbidities∗ | |||
Myocardial infarction | 1.3 | 1.0–1.7 | 0.04 |
Congestive heart failure | 3.1 | 2.1–4.5 | <0.001 |
PAD | 1.4 | 1.0–1.8 | 0.03 |
Diabetes with end organ failure | 1.2 | 1.0–1.3 | 0.02 |
Moderate – severe liver disease | 1.3 | 1.0–1.6 | 0.04 |
Note. HR, hazard ratio; CI, confidence interval; PAD, peripheral artery disease. ∗Charlson–Deyo index was analyzed for scoring points and in a second model using the same confounders for underlying comorbidities to avoid interactions.